Scientists are researching if a drug that’s being tested to treat a skin condition can also help keep COVID-19 patients off ventilators. The drug, labeled as EDP1815, was being tested on psoriasis patients, but Dr. Reynold Panettieri, vice chancellor for translational medicine and science at Rutgers University, said it will now be tested on coronavirus patients who have pneumonia and inflammation of the lungs. To read the full article.
Recent Posts
- NIH Fellowship Writing Group: Call for Applications – Sign Up by 8/25
- Rutgers Students Showcase AI-Driven Research Success Through NJ ACTS Summer Research Program
- Rutgers NJHealth Study Data Access Opportunity – Application Due July 6th!
- Rutgers researchers: How Meta turned teen attention into a public health crisis.
- Kids under 5 are grabbing their parents’ vapes and getting sick at record levels, researchers say.
Categories
- Community (2,498)
- Covid (1,001)
- CTO Events (6)
- News (3,172)
- Pilots (21)